Polymorphisms in hypocretin/orexin pathway genes and narcolepsy
- 27 November 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 57 (10) , 1896-1899
- https://doi.org/10.1212/wnl.57.10.1896
Abstract
The neuroexcitatory peptide hypocretin and its receptors are central to the pathophysiology of both human and animal models of the disease. In this study of American and Icelandic patients with narcolepsy, the authors found no significant association between narcolepsy and single-nucleotide polymorphisms in the genes for hypocretin or its two known receptors, hypocretin receptor-1 and hypocretin receptor-2.Keywords
This publication has 9 references indexed in Scilit:
- Reduced Number of Hypocretin Neurons in Human NarcolepsyNeuron, 2004
- Relevance of IGF-I, IGFBP-3, and IGFBP-2 Measurements during GH Treatment of GH-Deficient and Non-GH-Deficient Children and AdolescentsHormone Research in Paediatrics, 2001
- Hypocretin Levels in Sporadic and Familial Cases of Canine NarcolepsyNeurobiology of Disease, 2001
- A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNature Medicine, 2000
- Hypocretin (orexin) deficiency in human narcolepsyThe Lancet, 2000
- Using Quality Measures to Facilitate Allele Calling in High-Throughput GenotypingGenome Research, 1999
- Narcolepsy in orexin Knockout Mice: Molecular Genetics of Sleep RegulationPublished by Elsevier ,1999
- The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 GenePublished by Elsevier ,1999
- The neurobiology of narcolepsy-cataplexyProgress in Neurobiology, 1993